相关实验视频

Updated: Jan 17, 2026

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Published on: January 3, 2013

在胰腺管道腺癌中SGLT2的免疫组织化学表达

Shristi Butta¹, Manoj Gupta²

¹Pathology/Oncopathology, Institute of Post Graduate Medical Education and Research (IPGMER) and Seth Sukhlal Karnani Memorial Hospital (SSKM) Hospital, Kolkata, IND.

|September 15, 2025

概括

-葡萄糖运输蛋白2 (SGLT2) 表达与胰腺癌的等级和阶段有关. 抑制SGLT2可能为晚期胰腺管道腺癌提供一种新的治疗方法.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生化学

背景情况:

胰腺管道腺癌 (PDAC) 是一种高度侵袭性的癌症.
-葡萄糖运输蛋白2 (SGLT2) 在细胞能量代谢中发挥作用.
了解PDAC中的SGLT2表达对于开发向疗法至关重要.

研究的目的:

研究SGLT2在PDAC的各种组织学等级和瘤阶段的表达.
确定SGLT2免疫表达和PDAC的临床病理特征之间的相关性.

主要方法:

对41个PDAC案件进行了回顾性分析.
使用抗SGLT2抗体进行免疫组织化学 (IHC).
SGLT2表达与组织学等级和瘤阶段的相关性.

主要成果:

SGLT2免疫表达与组织学等级 (p=0.0001) 有意义地相关.
SGLT2免疫表达与瘤阶段有显著的关联 (p=0.0002).
血糖耐受性下降或糖尿病的积极病史与PDAC组织学等级 (p=0.0053) 有关.

结论:

SGLT2免疫表达是PDAC进展的重要生物标志物.
准SGLT2可能是PDAC的一种有前途的治疗策略.
对PDACSGLT2抑制的进一步研究是有必要的.

关键词:

管道胰腺癌癌瘤.基因病理学等级基因病理学等级免疫组织化学 (ihc)sglt2 基因基因基因基因基因瘤的阶段瘤的阶段

更多相关视频

Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation

Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation

Published on: August 7, 2015

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Published on: October 9, 2018

相关概念视频